Xin Lang Cai Jing·2026-03-31 00:03Core Viewpoint - The chairman and executive director of China Biologic Products Holdings, Xie Qirun, has increased his stake in the company by purchasing 1.748 million shares at a price of HKD 5.73 per share, totaling approximately HKD 10.016 million, resulting in a new holding of about 7.748 million shares, representing 0.04% of the company [1][2]. Summary by Category - Share Purchase Details - Xie Qirun acquired 1.748 million shares of China Biologic Products at HKD 5.73 each [1][2] - The total investment amounted to approximately HKD 10.016 million [1][2] - Post-Purchase Holdings - After the purchase, Xie Qirun's total shareholding increased to approximately 7.748 million shares [1][2] - The new shareholding percentage is 0.04% of the total shares [1][2]